Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems

NAEnrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Childhood CancerHematological Disorders
Interventions
DIAGNOSTIC_TEST

Physical examination

A physical examination to measure the patients' weight, height, body mass index, blood pressure and testicular volume using a Prader orchidometer and to determine the patients' Tanner stage (secondary sexual development).

DIAGNOSTIC_TEST

Scrotum ultrasound

A scrotum ultrasound to measure the patients' testicular volume and to investigate potential abnormalities in the testicular parenchyma.

DIAGNOSTIC_TEST

Blood sample

A morning blood sample to evaluate the serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone (T), estradiol (E2), inhibin B (INHB), thyroid-stimulating hormone (TSH), free thyroxine (FT4), insulin-like growth factor 1 (IGF1), prolactin (PRL), cortisol and adrenocorticotropic hormone (ACTH). Upon approval by the patient himself, a spare blood sample will be collected and retained for 5 years for subsequent research purposes limited to the context of the present study.

DIAGNOSTIC_TEST

Semen analysis

A semen analysis to evaluate ejaculate volume, sperm concentration, sperm motility, and sperm morphology. If sperm is found in the semen sample, an anti-sperm antibody test and a sperm DNA fragmentation test will be performed. Upon approval by the patient himself, the surplus of the semen sample will be retained for 5 years for subsequent research purposes limited to the context of the present study.

Trial Locations (1)

1090

Universitair Ziekenhuis Brussel, Brussels

All Listed Sponsors
collaborator

Vrije Universiteit Brussel

OTHER

lead

Universitair Ziekenhuis Brussel

OTHER